Trial Profile
Safety study of NaPPS in pediatric patients with mucopolysaccharidosis type VI
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 11 Jun 2016
Price :
$35
*
At a glance
- Drugs Pentosan polysulfate (Primary)
- Indications Mucopolysaccharidosis VI
- Focus Adverse reactions
- Sponsors ReqMed
- 11 Jun 2016 New trial record